In contrast to mice, rather increased expression of intestinal IL-22BP was observed in patients with IBD, and CD4+ T cells [84] and eosinophils [87] have been proposed as the cellular source of IL-22BP. This evidence concerns the gene IL22RA2 and inflammatory bowel disease.